Abstract
Shock wave therapy (SWT) reportedly improves ventricular function in ischemic heart failure. Angiogenesis and inflammation modulatory effects were described. However, the mechanism remains largely unknown. We hypothesized that SWT modulates inflammation via toll-like receptor 3 (TLR3) through the release of cytosolic RNA. SWT was applied to human umbilical vein endothelial cells (HUVECs) with 250 impulses, 0.08 mJ/mm2 and 3 Hz. Gene expression of TLR3, inflammatory genes and signalling molecules was analysed at different time points by real-time polymerase chain reaction. SWT showed activation of HUVECs: enhanced expression of TLR3 and of the transporter protein for nucleic acids cyclophilin B, of pro-inflammatory cytokines cyclophilin A and interleukin-6 and of anti-inflammatory interleukin-10. No changes were found in the expression of vascular endothelial cell adhesion molecule. SWT modulates inflammation via the TLR3 pathway. The interaction between interleukin (IL)-6 and IL-10 in TLR3 stimulation can be schematically seen as a three-phase regulation over time.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Similar content being viewed by others
Abbreviations
- CYP:
-
Cyclophilin
- DNA:
-
Deoxyribonucleic acid
- dsRNA:
-
Double-stranded ribonucleic acid
- HUVEC:
-
Human umbilical vein endothelial cell
- IL:
-
Interleukin
- PCR:
-
Polymerase chain reaction
- Poly(I:C):
-
Polyinosinic:polycytidylic acid
- Tie2:
-
Tyrosine kinase with immunoglobulin-like and EGF-like domains 2
- TLR3:
-
Toll-like receptor 3
- VCAM:
-
Vascular endothelial cell adhesion molecule
References
Nahrendorf, M., M.J. Pittet, and F.K. Swirski. 2010. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121(22): 2437–2445.
Haupt, G., A. Haupt, A. Ekkernkamp, B. Gerety, and M. Chvapil. 1992. Influence of shock waves on fracture healing. Urology 39: 529–532.
Chen, Y.J., C.J. Wang, K.D. Yang, Y.R. Kuo, H.C. Huang, Y.T. Huang, Y.C. Sun, and F.S. Wang. 2004. Extracorporeal shock waves promote healing of collagenase-induced Achilles tendinitis and increase TGF-beta1 and IGF-I expression. Journal of Orthopaedic Research 22: 854–861.
Fukumoto, Y., A. Ito, T. Uwatoku, T. Matoba, T. Kishi, H. Tanaka, A. Takeshita, K. Sunagawa, and H. Shimokawa. 2006. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coronary Artery Disease 17: 63–70.
Wang, C.J., K.D. Yang, F.S. Wang, C.C. Hsu, and H.H. Chen. 2004. Shock wave treatment shows dose-dependent enhancement of bone mass and bone strength after fracture of the femur. Bone 34: 225–230.
Schaden, W., R. Thiele, C. Kolpl, M. Pusch, A. Nissan, C.E. Attinger, M.E. Maniscalco-Theberge, G.E. Peoples, E.A. Elster, and A. Stojadinovic. 2007. Shock wave therapy for acute and chronic soft tissue wounds: a feasibility study. Journal of Surgical Research 143: 1–12.
Davis, T.A., A. Stojadinovic, K. Anam, M. Amare, S. Naik, G.E. Peoples, D. Tadaki, and E.A. Elster. 2009. Extracorporeal shock wave therapy suppresses the early proinflammatory immune response to a severe cutaneous burn injury. International Wound Journal 6(1): 11.
Wang, Y., T. Guo, H.Y. Cai, T.K. Ma, S.M. Tao, S. Sun, et al. 2010. Cardiac shock wave therapy reduces angina and improves myocardial function in patients with refractory coronary artery disease. Clinical Cardiology 33(11): 693–699.
Zuozienė, G., A. Laucevičius, and D. Leibowitz. 2012. Extracorporeal shockwave myocardial revascularization improves clinical symptoms and left ventricular function in patients with refractory angina. Coronary Artery Disease 23(1): 62–67.
Tepeköylü, C., FS. Wang, R. Kozaryn, K. Albrecht-Schgoer, M. Theurl, W. Schaden, HJ. Ke, Y. Yang, R. Kirchmair, M. Grimm, CJ. Wang, and J. Holfeld. 2013. Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis. The Journal of Thoracic and Cardiovascular Surgery. doi:10.1016/j.jtcvs.2013.01.017.
Zimpfer, D., S. Aharinejad, J. Holfeld, A. Thomas, J. Dumfarth, R. Rosenhek, M. Czerny, W. Schaden, M. Gmeiner, E. Wolner, and M. Grimm. 2009. Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure. The Journal of Thoracic and Cardiovascular Surgery 137(4): 963–970.
Kuo, Y.R., C.T. Wang, F.S. Wang, K.D. Yang, Y.C. Chiang, and C.J. Wang. 2009. Extracorporeal shock wave treatment modulates skin fibroblast recruitment and leukocyte infiltration for enhancing extended skin-flap survival. Wound Repair and Regeneration 17(1): 80–87.
Martini, L., G. Giavaresi, M. Fini, P. Torricelli, V. Borsari, R. Giardino, M. De Pretto, D. Remondini, and G.C. Castellani. 2005. Shock wave therapy as an innovative technology in skeletal disorders: study on transmembrane current in stimulated osteoblast-like cells. The International Journal of Artificial Organs 28(8): 841–847.
Alexopoulou, L., A.C. Holt, R. Medzhitov, and R.A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413(6857): 732–738.
Takeda K, Akira S. Toll-like receptors. Curr Protoc Immunol. 2007 May; Chapter 14: Unit 14.12.
Chi, H., S.P. Barry, R.J. Roth, J.J. Wu, E.A. Jones, A.M. Bennett, and R.A. Flavell. 2006. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci USA 103(7): 2274–2279.
Siow, R.C. 2012. Culture of human endothelial cells from umbilical veins. Methods in Molecular Biology 806: 265–274.
Paulus, P., E.R. Stanley, R. Schäfer, D. Abraham, and S. Aharinejad. 2006. Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts. Cancer Research 66(8): 4349–4356.
Payeli, S.K., C. Schiene-Fischer, J. Steffel, G.G. Camici, I. Rozenberg, T.F. Lüscher, and F.C. Tanner. 2008. Cyclophilin A differentially activates monocytes and endothelial cells: role of purity, activity, and endotoxin contamination in commercial preparations. Atherosclerosis 197(2): 564–571.
Ross, E.A., M.R. Douglas, S.H. Wong, E.J. Ross, S.J. Curnow, G.B. Nash, E. Rainger, D. Scheel-Toellner, J.M. Lord, M. Salmon, and C.D. Buckley. 2006. Interaction between integrin alpha9beta1 and vascular cell adhesion molecule-1 (VCAM-1) inhibits neutrophil apoptosis. Blood 107(3): 1178–1183.
Frangogiannis, N.G., C.W. Smith, and M.L. Entman. 2002. The inflammatory response in myocardial infarction. Cardiovascular Research 53: 31–47.
Steffens, S., F. Montecucco, and F. Mach. 2009. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury. Thrombosis and Haemostasis 102: 240–247.
Acknowledgments
This work was in part funded by a research grant from Bayer Pharma AG (Grants4Targets) to P.P. and by Medizinischer Forschungsfonds Tirol (MFF) project no. 220 to J.H. The sponsors of this study had no role in study design, data collection, analysis, and decision to publish or prepare the manuscript nor have any financial interest.
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Holfeld, J., Tepeköylü, C., Kozaryn, R. et al. Shockwave Therapy Differentially Stimulates Endothelial Cells: Implications on the Control of Inflammation via Toll-Like Receptor 3. Inflammation 37, 65–70 (2014). https://doi.org/10.1007/s10753-013-9712-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-013-9712-1